Clinical Trial Detail

NCT ID NCT02981524
Title Phase 2 Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

colorectal cancer

Therapies

Cyclophosphamide + GVAX colorectal cancer vaccine + Pembrolizumab

Age Groups: adult senior

No variant requirements are available.